First human test: new drug meets common heart pills
Knowledge-focused
Recruiting now
This is an early safety study to see how a new drug, JP-1366, interacts with four common heart and blood clot medications (clopidogrel, aspirin, atorvastatin, and apixaban). It will involve 96 healthy volunteers to check if taking JP-1366 with these drugs is safe and to measure h…
Phase: PHASE1 • Sponsor: Onconic Therapeutics Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC